跳至主要内容
临床试验/DRKS00029623
DRKS00029623已完成未知

In vivo evaluation of mucoadhesive minitablets compared to non-adhesive minitablets - MRI_mucoadhesive minitablets

Institut für Pharmazie, Biopharmazie & Pharmazeutische Technologie0 个研究点目标入组 12 人开始时间: 2022年8月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
All

入选标准

  • written informed consent (Einverständniserklärung”) ICF must be obtained before any assessment is performed
  • - age: 18 - 45 years
  • - sex: male and female
  • - ethnic origin: Caucasian
  • - body mass index: 18.0 to 30 kg/m²
  • - good health as evidenced by the results of the physical examination, which are judged by the responsible physician not to differ in a clinical relevant way from the normal state

排除标准

  • - Current participation in any clinical study including the use of any investigational drugs at the time of enrolment, or within 5 half-lives of enrolment, whichever is longer; or longer if required by local regulations
  • - weight less than 45 kg
  • - any contraindications for MRI including but not limited to the following: any metal bearing implants (excluding dental retainer), cardiac pacemakers, brain aneurysm clip, implanted cardiac pacemaker, pacemaker wires or defibrillator, prosthetic heart valves, cochlear implant, ocular foreign body (e.g. metal shavings), implanted insulin pump, tattoos (as determined by imager) or claustrophobia
  • - known allergic reactions or food intolerances to capsule and/or tablet materials
  • - gastrointestinal diseases and/or pathological findings, which might interfere with gastrointestinal motility and emptying processes
  • - drug or alcohol dependence
  • - smokers of 10 or more cigarettes per day
  • - subjects who are on a diet which could affect gastrointestinal motility (vegetarian, vegan)
  • - eating disorders e.g. anorexia, bulimia
  • - heavy tea or coffee drinkers (more than 1L per day)
  • - lactating and pregnant women (positive urine test)
  • - subjects suspected or known not to follow instructions
  • - subjects who are unable to understand the written and verbal instructions, regarding the risks and inconveniences they will be exposed to as a result of their participation in the study
  • - history of orthostatic dysregulation, fainting, or blackouts
  • - less than 2 weeks after last acute disease
  • - less than 1 week after last blood donation
  • - therapy with transdermal patches

研究者

发起方
Institut für Pharmazie, Biopharmazie & Pharmazeutische Technologie

相似试验